Can chronic use of Pepto‑Bismol (bismuth subsalicylate) cause black vomit, and is it safe to continue taking it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Black Vomit from Chronic Pepto-Bismol Use

Black vomit (emesis) from chronic Pepto-Bismol (bismuth subsalicylate) use is almost certainly a harmless cosmetic effect caused by bismuth deposition, but you must immediately discontinue the medication and evaluate for true gastrointestinal bleeding, especially given the duration of use ("last years").

Understanding the Black Discoloration

Bismuth subsalicylate causes a well-documented, harmless darkening of the stool and/or tongue that is temporary and reversible 1. This occurs because bismuth reacts with trace amounts of sulfur in the gastrointestinal tract to form bismuth sulfide, a black compound 2, 3. When vomiting occurs in someone taking Pepto-Bismol, this black discoloration can appear in the vomitus, mimicking the appearance of "coffee-ground" emesis from true GI bleeding.

Critical Safety Concerns with Chronic Use

Immediate Actions Required:

  1. Stop Pepto-Bismol immediately - The FDA label explicitly warns to discontinue use if symptoms last more than 2 days 1

  2. Rule out true GI bleeding - Black vomit can indicate:

    • Upper GI bleeding (peptic ulcer, gastritis, esophageal varices)
    • The FDA label specifically warns not to use if you have "bloody or black stool" or "an ulcer" 1
    • Examine for other signs: hemodynamic instability, anemia, melena, hematemesis without bismuth exposure
  3. Assess for salicylate toxicity - Chronic use over years poses serious risk:

    • The salicylate component is >90% absorbed systemically 3
    • Chronic toxicity presents with confusion, tinnitus, hearing loss, and falls 4
    • One case report documented a patient taking 1-2 bottles daily who developed severe confusion and hearing impairment with plasma salicylate levels at the upper therapeutic range 4
  4. Assess for bismuth toxicity - Though rare, chronic use can cause:

    • Neurotoxicity with confusion, myoclonus, tremors, gait instability, and visual hallucinations 5
    • While bismuth absorption is minimal (<0.005%), extended dosing can accumulate 3

Why Chronic Use Is Inappropriate

Pepto-Bismol is approved only for short-term use - maximum 2 days for acute symptoms 1. The evidence supporting safety extends only to 3-4 weeks maximum 3, and even the most liberal guideline recommendations (for microscopic colitis) note concerns about "long-term treatment being associated with salicylate or bismuth toxicity" 6.

Specific Contraindications in Your Case:

  • Duration: Years of use far exceeds any studied or recommended timeframe
  • Underlying pathology: Chronic symptoms requiring years of treatment suggest an undiagnosed condition (GERD, peptic ulcer disease, microscopic colitis, etc.) that needs proper evaluation and treatment
  • FDA warnings: The label states "Stop use and ask a doctor if symptoms get worse or last more than 2 days" 1

Recommended Management Algorithm

Step 1: Immediate Discontinuation

  • Stop all bismuth subsalicylate products now
  • Do not restart without physician supervision

Step 2: Urgent Evaluation for GI Bleeding

  • Complete blood count to assess for anemia
  • Stool guaiac testing (after bismuth clears system in 24-48 hours)
  • Consider upper endoscopy if any concerning features present

Step 3: Toxicity Assessment

  • Check salicylate level if symptomatic (confusion, tinnitus, hearing changes)
  • Serum and urine bismuth levels if neurological symptoms present 5
  • Supportive care with IV fluids if toxicity confirmed 4

Step 4: Identify and Treat Underlying Condition

  • Upper endoscopy for chronic upper GI symptoms
  • Test for H. pylori - if positive, treat with appropriate regimen (bismuth quadruple therapy uses bismuth differently in a structured 14-day protocol) 7, 8
  • Consider PPI therapy for GERD or peptic ulcer disease
  • Colonoscopy with biopsies if chronic diarrhea to evaluate for microscopic colitis

Common Pitfalls to Avoid

  • Don't assume all black vomit is from bismuth - Always rule out true bleeding first
  • Don't continue bismuth "because it helps" - Chronic symptoms require proper diagnosis and targeted therapy
  • Don't ignore subtle toxicity symptoms - Confusion, tinnitus, or gait changes in elderly patients on chronic bismuth may be attributed to aging but could be drug toxicity 4, 5
  • Don't use bismuth subsalicylate in children/teenagers with viral illnesses - Risk of Reye's syndrome 1

Bottom Line

The black emesis is likely harmless bismuth staining, but years of continuous Pepto-Bismol use is medically inappropriate, potentially dangerous, and masks an underlying condition that requires proper diagnosis and treatment. Discontinue immediately and seek comprehensive gastroenterological evaluation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.